$57.5 Million

scPharmaceuticals Inc.

Follow-on Offering

Bookrunner, November 2022

scPharmaceuticals Inc.

scPharmaceuticals, Inc. (“scPharma” or the “Company”) (NASDAQ: SCPH) is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. ScPharma’s strategy is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous (“IV”) delivery. By moving delivery away from the high-cost healthcare settings typically required for IV administration, the Company believes their technology has the potential to reduce overall healthcare costs and advances the quality and convenience of care.